From: The cost-effectiveness of early noninvasive ventilation for ALS patients
Variables | Reference case | Lower value tested | Upper value tested |
---|---|---|---|
Probabilities: | Â | Â | Â |
   NIPPV tolerance | 0.49[3] | 0.40 | 0.80 |
   Staying mild | 0.66[14] | 0.60 | 0.70 |
   Staying moderate | 0.77[14] | 0.70 | 0.80 |
   Staying severe | 0.76[14] | 0.70 | 0.80 |
   Staying terminal | 0.78[14] | 0.70 | 0.80 |
Utilities: | Â | Â | Â |
   Mild | 0.8[15] | 0.7 | 0.9 |
   Moderate | 0.6[15] | 0.5 | 0.7 |
   Severe | 0.5[15] | 0.4 | 0.6 |
   Terminal | 0.4[15] | 0.3 | 0.5 |
Costs: | Â | Â | Â |
   NIPPV and accessories for 1 year | $3,132[17] | $2,810 | $3,306 |
   A trial of NIPPV in those who prove intolerant | $467[17] | $411 | $483 |